Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
AssigneeTakeda Pharmaceuticals U.S.A., Inc.
InventorsDavid Baron, Keisuke Hirai, Yasushi Shintani, Osamu Uchikawa
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions and methods for treating and/or preventing age-related macular degeneration with melatonin analogues are provided.
Claims23
A method for treating age-related macular degeneration in a patient in need thereof, wherein said method comprises identifying a patient in need of treatment for age-related macular degeneration, and administering (S)—N-[2-[4-hydroxy-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]propionamide to said patient.
A method for treating age-related macular degeneration in a patient in need thereof, wherein said method comprises administering (S)—N-[2-[4-hydroxy-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]propionamide to said patient.
Dependencies are inferred from the claim text.